The neglected burden of Plasmodium vivax malaria.

By K. Mendis, Barbara J. Sina, Paola Marchesini, R. Carter. American Journal of Tropical Medicine and Hygiene, 2001

1,073 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

A World Malaria Map: Plasmodium falciparum Endemicity in 2007 (2009, neutral): “Plasmodium vivax [71-73].”
Vivax malaria (2007, background): “vivax.(2,33) However, these rates may not necessarily be extrapolated to other endemic areas.”
Determinants of relapse periodicity in Plasmodium vivax malaria (2011, background): “There are major questions about the basic biology and the epidemiology of Plasmodium vivax relapse which first need recognizing, and then need answering, if we are to address seriously controlling and eliminating this important malaria parasite [165].”
Evolutionary and Historical Aspects of the Burden of Malaria (2002, background): “vivax has proved itself to be the most tenacious survivor of all the malaria parasites of humans (131).”
Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia (2008, background): “vivax is widely regarded as benign, its propensity to recur is increasingly recognized by clinicians in endemic areas to result in appreciable disease, particularly in young children [2,3].”